Among them, the microgel with 20.7 mol % and a narrow particle size distribution is appropriate for diabetes treatment because it can adapt to the various glucose levels in the extracellular environment over a clinically significant range (0–2.0 mgmL−1), controlled release of loaded insulin, and is extremely stable under physiological circumstances. The gene discussed is INS; the disease is diabetes mellitus.